| Bioactivity | PCSK9-IN-23 (compound 5C) is a potent PCSK9 inhibitor. PCSK9-IN-23 blocks PCSK9 secretion from HepG2 cells, significantly increases LDL receptor (LDLR) expression[1]. |
| Name | PCSK9-IN-23 |
| CAS | 2115700-96-2 |
| Formula | C22H18F6N2O |
| Molar Mass | 440.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lisa Giannessi, et al. Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability. Eur J Med Chem. 2023 Dec 20:265:116063. |
PCSK9-IN-23
CAS: 2115700-96-2 F: C22H18F6N2O W: 440.38
PCSK9-IN-23 (compound 5C) is a potent PCSK9 inhibitor. PCSK9-IN-23 blocks PCSK9 secretion from HepG2 cells, significantl
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.